More Technical Information Than You Can Handle. 
 

.
 

‘Pick and mix’ technology promises...

 
LONDON, UK - Imperial College-based biotech startup Baseimmune has secured $4.8m funding to develop the next generation of future-proof universal vaccines against major human and animal diseases.   Around 1.5 million people die every year around the world due to a lack of effective vaccines.* There is an urgent need to develop better universal vaccines against existing diseases, including, COVID, flu and malaria, as well as future-proof vaccines that can cope with the emergence of... Source: RealWire

- View Press Release

RealWire
Posted: November 2, 2021 |  By: Wissen Schwamm
Recent RealWire related news.
Hampleton Partners advises akquinet enterprise solutions GmbH on its acquisition by Pathlock backed by Vertica Capital Partners
Faculty launches "Frontier" to drive better organisational decision making
3 in 5 Organizations Experienced Accidental Data Loss Over Email in the Past Year
Egress Mid-Year Threat Report Details Scams Affecting Cryptocurrency-based Ukraine Donations, Job Seekers, Electronic Voters, and More
OSL and BSO unveil strategic partnership to bolster connectivity for institutional exchange clients
+ View more RealWire related news +